Latest updates for Verx

Fresh curated links around VERX are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • vexora sera
  • Monte Rosa: Initiating Coverage With A Buy On Degrader Platform Potential
  • Volex plc 2026 Q4 - Results - Earnings Call Presentation

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

mql5.com /1 week ago

vexora sera

Read source
seekingalpha.com /1 month ago

Monte Rosa: Initiating Coverage With A Buy On Degrader Platform Potential

Read source
seekingalpha.com /3 weeks ago

Volex plc 2026 Q4 - Results - Earnings Call Presentation

Read source
mql5.com /1 month ago

VEXORA NOX

Read source
mql5.com /1 month ago

VEXORA NOX

Read source
mql5.com /1 month ago

VEXORA NOX

Read source
seekingalpha.com /1 month ago

URTH: A Guide To This U.S.-Centric Developed Market Portfolio

Read source
newswire.com /1 month ago

OSR Holdings Acquires Full VXM01 Intellectual Property Portfolio in $30 Million Transaction

Transaction Centralizes VXM01 Ownership and Long-Term Royalty Economics at the OSRH Parent Level

Read source
finance.yahoo.com /2 weeks ago

Verra Mobility (VRRM) Selected to Implement Los Angeles Speed Safety Program

Read source
fool.com /2 weeks ago

Why Vertex Stock Is Rising Today

One firm sees room for this tech stock to run.

Read source
investing.com /3 weeks ago

Form 144 Vera Therapeutics For: 23 June

Read source
seekingalpha.com /1 month ago

Elevra Lithium Limited (ELVR) Presents at ASX CEO Connect June 2026 - Slideshow

Read source
newswire.com /1 month ago

REX-Osprey(TM) ETH + Staking ETF (ESK) TO LIQUIDATE

Read source
cafepharma.com /2 weeks ago

Vera Therapeutics

Vera Therapeutics Anonymous (not verified) Wed, 07/01/2026 - 06:05 field_thread_url https://cafepharma.com/boards/threads/vera-therapeutics.713115/...

Read source
vuejobs.com /4 weeks ago

UX Design Manager

Employer: Veracross Location: Wakefield, Massachusetts, US Company Description: Veracross provides SaaS-based School Information...

Read source
seekingalpha.com /3 weeks ago

XOVR: A Private-Public Crossover ETF You Need To Know

Read source
seekingalpha.com /1 month ago

V2X: Backlog Has Improved, But The Stock Already Reflects Much Of It

Read source
newswire.com /1 month ago

Emerging Growth Research Initiates Coverage on Virtuix Holdings Inc. (VTIX) with Buy-Emerging Rating and $9.00 Price Tar...

Read source
seekingalpha.com /1 month ago

Voyager Technologies Is Set To Launch In 2027 And Beyond (Rating Upgrade)

Read source
seekingalpha.com /1 month ago

Versigent PLC (VGNT) Presents at UBS Auto and Auto Tech Conference 2026 Transcript

Read source
cafepharma.com /1 month ago

Averitas

Averitas Anonymous (not verified) Wed, 05/27/2026 - 11:39 field_thread_url https://cafepharma.com/boards/threads/averitas.667825/ board...

Read source
prweb.com /1 month ago

Veritac Group Launches to Help Investor-Backed Mid-Market Companies Build Scalable Revenue Engines

Founded by veteran operators David Garcia and Erika Rosenthal, Veritac Group embeds with CEOs and investors to strengthen mid-market companies' go-to-market strategy, revenue opera...

Read source
seekingalpha.com /4 weeks ago

Virtus Ceredex Small-Cap Value Equity Fund Q1 2026 Commentary

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Verx

seekingalpha.com

Recent coverage from public sources
Public source

cafepharma.com

Recent coverage from public sources
Public source

finance.yahoo.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

vuejobs.com

Recent coverage from public sources
Public source

fool.com

Recent coverage from public sources
Public source